Average Insider

Where insiders trade, we follow

Hohl Benjamin

CHIEF FINANCIAL OFFICER
CIK: 1882764

All Transactions

DateCompanyTypeSharesPriceValueActions
Mar 6, 2026Enliven Therapeutics, Inc. (ELVN)S10,000$29.58$295,839.00View Details Filing
Feb 12, 2026Enliven Therapeutics, Inc. (ELVN)A150,000$0.00$0.00View Details Filing
Feb 12, 2026Enliven Therapeutics, Inc. (ELVN)A25,000$0.00$0.00View Details Filing
Dec 22, 2025Enliven Therapeutics, Inc. (ELVN)M13,000$0.00$0.00View Details Filing
Dec 22, 2025Enliven Therapeutics, Inc. (ELVN)M13,000$2.48$32,240.00View Details Filing
Version: v26.3.23